EXECUTIVE SUMMARY:
This final report found the NIH did not have adequate: (1) accounting of the status of its patent properties; (2) procedures to ensure that technology, once transferred, was developed, commercialized and receiving its proper share of royalty inocme; and (3) procedures to ensure timely decisions and coordination for filing of foreign patent rights. The PHS in response to our report, stated that improvements and innovations have been made which have significantly changed the management and oversight of the technology transfer program and corrected material internal control weaknesses.